Evidence map›Paper›PMID 33019532›Full record

ArticleBiomolecules2020

Dissecting the Interaction of FGF8 with Receptor FGFRL1.

Lei Zhuang, Monique Vogel, Peter M Villiger, Beat Trueb

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. The Influence of theAnimals : an open access journal from MDPI · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lei ZhuangDepartment for BioMedical Research, University of Bern, 3008 Bern, Switzerland.
Monique VogelDepartment for BioMedical Research, University of Bern, 3008 Bern, Switzerland.
Peter M VilligerDepartment of Rheumatology, University Hospital, 3010 Bern, Switzerland.
Beat TruebDepartment for BioMedical Research, University of Bern, 3008 Bern, Switzerland.ORCID 0000-0001-8684-6856
University of Bern · CHUniversity Hospital of Bern · CH

Funding

Stiftung für die Erforschung der Muskelkrankheiten 12-2015
6 · The paper itself

Abstract

In mammals, the novel protein fibroblast growth factor receptor-like 1 (FGFRL1) is involved in the development of metanephric kidneys. It appears that this receptor controls a crucial transition of the induced metanephric mesenchyme to epithelial renal vesicles, which further develop into functional nephrons. FGFRL1 knockout mice lack metanephric kidneys and do not express any fibroblast growth factor (FGF) 8 in the metanephric mesenchyme, suggesting that FGFRL1 and FGF8 play a decisive role during kidney formation. FGFRL1 consists of three extracellular immunoglobulin (Ig) domains (Ig1-Ig2-Ig3), a transmembrane domain and a short intracellular domain. We have prepared the extracellular domain (Ig123), the three individual Ig domains (Ig1, Ig2, Ig3) as well as all combinations containing two Ig domains (Ig12, Ig23, Ig13) in recombinant form in human cells. All polypeptides that contain the Ig2 domain (Ig123, Ig12, Ig23, Ig2) were found to interact with FGF8 with very high affinity, whereas all constructs that lack the Ig2 domain (Ig1, Ig3, Ig13) poorly interacted with FGF8 as shown by ELISA and surface plasmon resonance. It is therefore likely that FGFRL1 represents a physiological receptor for FGF8 in the kidney and that the ligand primarily binds to the Ig2 domain of the receptor. With Biacore experiments, we also measured the affinity of FGF8 for the different constructs. All constructs containing the Ig2 domain showed a rapid association and a slow dissociation phase, from which a K

Indexed as

AnimalsEpithelial-Mesenchymal TransitionFibroblast Growth Factor 8HumansImmunoglobulin DomainsKidneyLigandsMiceMice, KnockoutNephronsReceptor, Fibroblast Growth Factor, Type 5Surface Plasmon ResonanceFGF8 protein, humanFGFRL1 protein, humanFibroblast Growth Factor 8LigandsReceptor, Fibroblast Growth Factor, Type 5FGF8FGFRL1fibroblast growth factor (FGF)fibroblast growth factor receptor (FGFR)kidney developmentmesenchymal-to-epithelial transition (MET)

Identifiers

PMID33019532
PMCPMC7600612
OpenAlexW3090030529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.